http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1771745-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140b7698343faff72c7e9e3edad13eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15eaf90aa6d8d3512ddb75eef798cac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eed123cc1ad87407542909696b07e053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf44e08d2623eddc611fa61883db3582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96f7ea173ebd7a1479f117c49092bcaa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
filingDate 1990-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f264b04d203d3d117f833fd2a0cbf18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029bbb4e4b74560b19ceb62dc0f40202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af49245ea749c6f401cedcc273f935be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68eea46c817e8fe06d7e2da63c13b71e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61fa026600c2fb7d4ce8e3542e4c68b9
publicationDate 1992-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1771745-C
titleOfInvention Method of septicopyemia treatment
abstract Usage: in obstetric and gynecological practice. Goal 1: reduction of mortality and reduction of treatment time. The essence of the method: against the background of complex drug therapy, fibrinolytic and lubricant drugs are dripped into the abdominal aorta through a catheter for 8-12 hours, then 3-4 times daily from the 2nd day. a complex of drugs and a donor suspension of 40-50 ml are administered through a catheter for 6-12 days, with a simultaneous compression of the femoral artery for 20-30 minutes per course of 100-300 ml. Positive effect: the proposed method for the treatment of septicolemia made it possible to reduce lethality by 7 times, the duration of treatment by an average of 9-10 days, and to maintain reproductive function in a number of patients.
priorityDate 1990-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454552460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531574

Total number of triples: 27.